AVERTOX
Welcome to the Brand page for “AVERTOX”, which is offered here for Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals containing galantamine; drug delivery agents in the form of capsules that provide controlled release of galantamine together with other pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of galantamine together with other pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of galantamine together with other pharmaceuticals; homeopathic pharmaceuticals for use in the treatment of organophosphate toxicity; inhalers filled with galantamine; pharmaceutical preparations containing galantamine acting on the central nervous system; pharmaceutical preparations and substances containing galantamine for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system toxicity related diseases and disorders; pharmaceutical preparations containing galantamine for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; pharmaceutical preparations containing galantamine for the treatment of inflammatory disorders; pharmaceutical preparations containing galantamine for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention of organophosphate toxicity; pharmaceutical preparations for the treatment of organophosphate toxicity; plant extracts containing galantamine for medical, veterinary and pharmaceutical purposes; syringes sold filled with galantamine; therapeutic pharmaceutical for the treatment of organophosphate toxicity;information leaflets concerning pharmaceuticals containing galantamine;chemical additives containing galantamine for use in the manufacture of tablets, injections, aerosols, gels, time-released products, therapeutic patches, prophylactic patches containing galantamine;.
Its status is currently believed to be active. Its class is unavailable. “AVERTOX” is believed to be currently owned by “Lynch, Ronald C.”
| Owner: |
LYNCH, RONALD C.
Owner Details |
|---|---|
| Description: |
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals containing galantamine; Drug delivery agents in the form of capsules that provide controlled release of galantamine together with other pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of galantamine together with other pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of galantamine together with other pharmaceuticals; Homeopathic pharmaceuticals for use in the treatment of organophosphate toxicity; Inhalers filled with galantamine; Pharmaceutical preparations containing galantamine acting on the central nervous system; Pharmaceutical preparations and substances containing galantamine for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system toxicity related diseases and disorders; Pharmaceutical preparations containing galantamine for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations containing galantamine for the treatment of inflammatory disorders; Pharmaceutical preparations containing galantamine for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention of organophosphate toxicity; Pharmaceutical preparations for the treatment of organophosphate toxicity; Plant extracts containing galantamine for medical, veterinary and pharmaceutical purposes; Syringes sold filled with galantamine; Therapeutic pharmaceutical for the treatment of organophosphate toxicity;Information leaflets concerning pharmaceuticals containing galantamine;Chemical additives containing galantamine for use in the manufacture of Tablets, Injections, Aerosols, Gels, Time-Released Products, therapeutic patches, prophylactic patches containing galantamine;
|
| Categories: | DRUG DELIVERY AGENTS CONSISTING |
